@article{96540b6b5c064755af879b0631d2ca78,
title = "Changes in heart rate in patients with type 2 diabetes mellitus after treatment with luseogliflozin: Subanalysis of placebo-controlled, double-blind clinical trials",
author = "Motoaki Sano and Shi Chen and Hisae Imazeki and Hidekazu Ochiai and Yutaka Seino",
note = "Funding Information: Boehringer Ingelheim Co., Ltd., Johnson & Johnson and Takeda Pharmaceutical Company Limited. YS also received clini cal commissioned/joint research grants from Nippon Boehringer Ingelheim Co., Ltd., Eli Lilly and Company, Taisho Toyama Pharmaceutical Co., Ltd., MSD K.K., Ono Pharmaceutical Co., Ltd., Novo Nordisk Pharma Ltd., and ARKRAY, Inc. MS received joint research grants from Taisho Toyama Pharmaceutical Co., Ltd. HI, HO and SC are employees of Taisho Pharmaceutical Co., Ltd.",
year = "2018",
month = may,
doi = "10.1111/jdi.12726",
language = "English",
volume = "9",
pages = "638--641",
journal = "Journal of Diabetes Investigation",
issn = "2040-1116",
publisher = "Blackwell Publishing Asia Pty Ltd",
number = "3",
}
